Advanced & breakthrough therapies: from idea to patient

QbD, Antleron, Inovigate, Eye-Tec, Neuroplast and Anicells would like to invite you to their event on Advanced & Breakthrough therapies. By means of different keynotes that afternoon, they intend to highlight the different aspects of the ATMP-lifecycle.


The afternoon will be ended with a panel discussion about "innovating end-to-end to win, from a single therapy and for the region". The panel will exist of Philippe De Backer, Pascale Engelen (, Annie Hubert (Alliance for Regenerative Medicine) and David Callaert (Novartis).


12.00h Welcome + lunch

13.00h Introduction – Bart Van Acker, CEO QbD

13.15h “GMP for ATMP: one year into the new part IV” – Bram Keymolen, co-founder Eye-Tec

14.00h “Innovative technologies fueling personalized cell therapy” – Jan Schrooten, CEO Antleron

14.45h BREAK

15.15h “Challenges in scaling and control strategy from lab to patient” – Nicolas Theys, Chief Operating Officer Novadip

16.00h “Lessons learned from the cell therapy trials. Time for a new approach?” – Jean-Paul Deslypere, CEO Aesculape

16.45h “Innovative Funding solutions for breakthrough therapies” – Ingrid Maes, Managing Director Inovigate BE

17.15h Panel discussion – “Innovating end-to-end to win, from a single therapy and for the region”
- Philippe De Backer
- Pascale Engelen, CO Managing Director
- Annie Hubert, Senior Director Alliance for Regenerative Medicine
- David Callaert, Head of Engineering Global BTDM at Novartis

18.15h Network Reception

Event Details


Thursday, June 13, 2019 (12:00 h - 20:00 h)


Living Tomorrow Brussels
1 Indringingsweg, 1800 Vilvorde


€ 150




QbD, Antleron, Anicells, Neuroplast, Eye-Tec en Inovigate. 

2019-06-13 12:00:00 2019-06-13 20:00:00 Europe/Brussels Advanced & breakthrough therapies: from idea to patient Living Tomorrow Brussels1 Indringingsweg, 1800 Vilvorde <p>QbD, Antleron, Anicells, Neuroplast, Eye-Tec en Inovigate. </p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Co-General Manager

Alternate Text

Pascale Engelen

Co-General Manager

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?